Profil
Hitoshi Miyakoshi joined Taiho ventures in 2021.
He worked at Taiho Pharmaceutical for 16 years as a medicinal chemist in drug discovery for anti-cancer agents.
He led cancer metabolism and brain cancer projects as a chemistry leader, including dUTPase/DPD dual inhibitor (TAS-114) and brain-penetrable drug discovery projects.
Besides that, he also engaged in open-innovation support in a wide range of drug discovery field at Taiho.
He received his PhD in pharmaceutical and medicinal chemistry from Gifu Pharmaceutical University.
Postes actifs de Hitoshi Miyakoshi
| Sociétés | Poste | Début |
|---|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, therapeutic, pharmaceutical, and health sectors. It participates in early stage capital requirements. | Private Equity Investor | 01/01/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, therapeutic, pharmaceutical, and health sectors. It participates in early stage capital requirements. | Finance |
















